Results 131 to 140 of about 31,151 (261)

Remote and On‐Site Working During the Covid‐19 Pandemic: (Re)Configuring Work Organisation in Border Control Services and the Nuclear Industry

New Technology, Work and Employment, EarlyView.
ABSTRACT During the COVID‐19 pandemic, the nuclear and border control services had to reorganise their work, both on‐site and remotely, to continue their activities. Whereas employees came to work at the power plants and border posts every day, the health rules introduced by the public authorities and those relating to the lockdown of populations ...
Laure Bonnaud, Tania Navarro Rodríguez
wiley   +1 more source

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation. [PDF]

NPJ Vaccines
Sherry L, Grehan K, Bahar MW, Swanson JJ, Fox H, Matthews S, Carlyle S, Qin L, Porta C, Wilkinson S, Robb S, Clark N, Liddell J, Fry EE, Stuart DI, Macadam AJ, Rowlands DJ, Stonehouse NJ.   +17 more
europepmc   +1 more source

Knocking Out Two Polyphenol Oxidase Genes Significantly Improves Recombinant Protein Purification in Nicotiana benthamiana

Plant Biotechnology Journal, EarlyView.
ABSTRACT Efficient purification remains a key technical challenge affecting the recovery efficiency of recombinant proteins in plant‐based systems. Complex metabolites, particularly polyphenols, often cause recombinant protein aggregation during purification.
Hai‐Ping Diao, Hui‐Xin Meng, Xue‐Jiao Xu, Zeng‐Lin Zhang, Jian‐Feng Zhang, Yong‐Feng Guo, Inhwan Hwang, Shi‐Jian Song   +7 more
wiley   +1 more source

Advances in African swine fever vaccine development: challenges and prospects. [PDF]

J Vet Sci
Utomo DIS, Dharmayanti NI, Putra MY.
europepmc   +1 more source

Chikungunya virus-like particle vaccine

Chikungunya virus (CHIKV) is an arthropod-borne alphavirus (family Togaviridae) and is the causative agent of chikungunya fever. This disease is characterised by the sudden onset of high fever and long-lasting arthritic disease. First identified in Tanzania in 1952, CHIKV has re-emerged in the last decade causing large outbreaks throughout Africa, Asia
openaire   +2 more sources

Application and Research Progress of Self-Assembling Protein Nanoparticles in Vaccine Development. [PDF]

Int J Mol Sci
Zhang Y, Ru Y, Li X, Wang G, Hu Y, Jian Y, Ma L.   +6 more
europepmc   +1 more source

From legacy to innovation: A comprehensive review of vaccine platforms against viral infections. [PDF]

Virus Res
Farsiu N, Khodadadpour Mahani F, Arefinia N, Charostad J, Pardeshenas M, Mirzaei H, Nakhaie M, Hassandarvish P, AbuBakar S.   +8 more
europepmc   +1 more source

Engineered PCV2 VLPs for Antigen Delivery: A Platform for Next-Generation Veterinary Vaccines. [PDF]

Transbound Emerg Dis
Ding P, Liu Y, Wang C, Wang A.
europepmc   +1 more source

Foot-and-mouth disease virus-like particle mRNA vaccine induces strong humoral and cellular immunity. [PDF]

Appl Microbiol Biotechnol
Liu H, Zhang Y, Mu S, Hou F, Jiang L, Wang Z, Dong H, Mehdi MM, Guo H, Sun S.   +9 more
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source